Barts Health NHS Trust
London, United Kingdom
Location status: Recruiting
Location contact
Dr Anne-Marie Beirne
CONTACT
NCT Number: NCT04440761
The last 15 years the introduction of primary angioplasty has radically improved outcomes for acute myocardial infarction (AMI). However, the system wide availability of prompt investigation has revealed an important group of patients where progress has stalled, the diagnosis is unclear and therapeutic approaches are uncertain. Myocardial infarction with non-obstructive coronary arteries (MINOCA) is found in 1 - 13% of all patients with a clinical diagnosis of AMI.
These patients present a therapeutic predicament since coronary revascularization is not appropriate. Guidelines do not exist for their management - yet the condition is not benign - the 12-month prognosis, although better than obstructive coronary artery disease patients is still guarded with recent data suggesting many questions remain unanswered.
Interested in participating?
Request Info16 year and older
All sexes
Observational
London, United Kingdom
Location status: Recruiting
Dr Anne-Marie Beirne
CONTACT
This study utilises a prospectively collected clinical database. All patients referred to the Interventional Cardiology team are included onto this database. No patients will be contacted solely for research purposes. Patients will not have any investigations/procedures performed for research purposes. All data will only be available for access by named members of the Interventional Cardiology team. Data will be anonymised by the clinical care team and passed onto the research team before it is used and no patient identifiable information will be used in the analysis of the study or the publications of its results.
The database started in April 2015 and has collected data on all patients so far and will continue to do so for the duration of clinical work by the Interventional Cardiology team. As a result this study will continue indefinitely.
This study will include all patients admitted to or reviewed in clinic at Barts Health NHS Trust with either a diagnosis of MINOCA or who do not have a clear cause of a troponin rise. These patients range from young adults to the elderly and will include any patient ≥16 years of age. Patients who are followed up with and without any intervention (i.e. both medically managed patients as well as patients undergoing intervention) are equally as important and therefore the investigators shall include both groups of patients.
Patients will be included from referrals made by other clinicians either as in or outpatients. All these patients have their clinical data captured on a database or hospital based clinical programme.
This study aims to assess, in a real-world setting, the safety, efficacy and feasibility of further investigations in patients diagnosed with MINOCA among all patients with coronary artery disease.
The study will test various hypothesis including but not limited to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observation only
Time frame: 30 days
Assessment of mortality
Time frame: 1 year
Assessment of mortality
Time frame: Baseline
Diagnosis
Time frame: Baseline
Time to first diagnosis
Time frame: 2 months
Change in symptoms assessed by Questionnaire
Contact information is provided by the study sponsor or research team.
Daniel Jones, MBBS, PhD
CONTACT
Krishnaraj Rathod, MBBS, PhD
CONTACT
Queen Mary University of London
Other
Barts Myocardial Infarction With Non-Obstructed Coronary Arteries (MINOCA) Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05793567
Angina Pectoris, Cardiovascular Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT04685941
Angina Pectoris, Cardiovascular Diseases
L'Hospitalet de Llobregat, Barcelona, Spain
View Trial DetailsNCT04202172
Angina Pectoris, Cardiovascular Diseases
L'Hospitalet de Llobregat, Barcelona, Spain
View Trial DetailsNCT02060760
Acute Coronary Syndrome, Behavior
Minneapolis, Minnesota, United States
View Trial Details